Pyrimethamine Market, By Dosage Form (Tablets and Capsules), By Strength (25 mg, 50 mg, 75 mg, and Others), By Indication (Malaria, Toxoplasmosis, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geo

Pyrimethamine Market, By Dosage Form (Tablets and Capsules), By Strength (25 mg, 50 mg, 75 mg, and Others), By Indication (Malaria, Toxoplasmosis, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)


Pyrimethamine is an antifolate drug used for the treatment of protozoan infections such as malaria and toxoplasmosis. It works by inhibiting dihydrofolate reductase (DHFR), an enzyme involved in folate synthesis. This prevents protozoan parasites from producing essential folate and halts their growth. Pyrimethamine is often used in combination with other antimalarial drugs to enhance efficacy and reduce resistance development. Resistance to pyrimethamine has emerged due to mutations in the DHFR gene among Plasmodium species, complicating treatment strategies. Consequently, ongoing research focuses on developing new inhibitors targeting DHFR or related pathways to combat resistant strains effectively:

Market Dynamics:

The pyrimethamine market is driven by the growing prevalence of malaria in tropical and subtropical regions globally. As per the WHO, in December 2023, the estimated number of malaria deaths stood at 608,000 in 2022 compared to 610,000 in 2021. Increasing anti-malarial drug resistance is also boosting the demand for alternative treatment options like pyrimethamine. However, stringent regulatory approval processes for new drugs and the need for close medical supervision due to potential side effects can hamper market growth. The market also presents opportunities for combinations with other antimalarials to expand treatment applications and overcome resistance. Entry of newer generic manufacturers especially in developing countries can help improve the accessibility of pyrimethamine.

Key features of the study:
  • This report provides in-depth analysis of the global pyrimethamine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pyrimethamine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Dr. Reddy's Laboratories Ltd., Alvogen, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., AdvaCare Pharma, Swipha, Cerovene Inc., Vyera Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pyrimethamine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pyrimethamine market.
Market Segmentation
  • By Dosage Form Insights (Revenue, USD Bn, 2019 - 2031)
  • Tablets
  • Capsules
  • By Strength Insights (Revenue, USD Bn, 2019 - 2031)
  • 25 mg
  • 50 mg
  • 75 mg
  • Others
  • By Indication Insights (Revenue, USD Bn, 2019 - 2031)
  • Malaria
  • Toxoplasmosis
  • Others
  • By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Reddy's Laboratories Ltd.
  • Alvogen
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer, Inc.
  • AdvaCare Pharma
  • Swipha
  • Cerovene Inc.
  • Vyera Pharmaceuticals


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Pyrimethamine Market, By Dosage Form
Pyrimethamine Market, By Strength
Pyrimethamine Market, By Indication
Pyrimethamine Market, By Distribution Channel
Pyrimethamine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Epidemiology
4. Pyrimethamine Market, By Dosage Form, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Tablets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Capsules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Pyrimethamine Market, By Strength, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
25 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
50 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
75 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Pyrimethamine Market, By Indication, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Malaria
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Toxoplasmosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Pyrimethamine Market, By Distribution Channel, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 - 2031
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Pyrimethamine Market, By Region, 2019 - 2031, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Strength, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Strength, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Strength, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Strength, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Strength, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Strength, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
South Africa
North Africa
Central Africa
9. Competitive Landscape
Reddy's Laboratories Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Alvogen
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AdvaCare Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Swipha
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Cerovene Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Vyera Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on 'Pyrimethamine Market' - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings